Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Gross Profit (2020 - 2025)

Historic Gross Profit for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to -$1.0 million.

  • iSpecimen's Gross Profit fell 19336.81% to -$1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$213769.0, marking a year-over-year decrease of 10428.83%. This contributed to the annual value of $4.0 million for FY2024, which is 2191.72% down from last year.
  • Latest data reveals that iSpecimen reported Gross Profit of -$1.0 million as of Q3 2025, which was down 19336.81% from $268958.0 recorded in Q2 2025.
  • iSpecimen's Gross Profit's 5-year high stood at $1.8 million during Q3 2021, with a 5-year trough of -$1.0 million in Q3 2025.
  • For the 5-year period, iSpecimen's Gross Profit averaged around $1.1 million, with its median value being $1.3 million (2022).
  • Its Gross Profit has fluctuated over the past 5 years, first surged by 12232.08% in 2024, then crashed by 19336.81% in 2025.
  • iSpecimen's Gross Profit (Quarter) stood at $1.3 million in 2021, then increased by 16.98% to $1.6 million in 2022, then fell by 26.04% to $1.1 million in 2023, then tumbled by 86.81% to $151352.0 in 2024, then plummeted by 783.38% to -$1.0 million in 2025.
  • Its Gross Profit was -$1.0 million in Q3 2025, compared to $268958.0 in Q2 2025 and $400231.0 in Q1 2025.